Red Violet, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RDVT research report →
Range $73 – $73
Price Chart
About the company
Red Violet, Inc. is a technology firm specializing in software and analytical services, leveraging its proprietary technology and advanced analytical prowess to deliver crucial identity intelligence solutions primarily within the United States. Among its flagship offerings is idiCORE, an investigative platform designed to tackle diverse corporate hurdles, including rigorous due diligence, proactive risk mitigation, robust identity verification, and adherence to regulatory mandates.
- CEO
- Derek Dubner
- IPO
- 2018
- Employees
- 250
- HQ
- Boca Raton, FL, US
Get TickerSpark's AI analysis on RDVT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $995.10M
- P/E
- 60.80
- Fwd P/E
- 43.11
- PEG
- 0.70
- P/S
- 10.05
- P/B
- 8.92
- EV/EBITDA
- 34.73
- Div Yield
- 0.00%
- Gross Margin
- 87.38%
- Op Margin
- 17.89%
- Net Margin
- 16.54%
- ROE
- 15.64%
- ROIC
- 13.15%
Latest fiscal year · YoY change
- Revenue
- $90.25M+20.0%
- Gross Profit
- $75.58M+23.5%
- Op Income
- $13.14M
- Net Income
- $13.15M+87.8%
- EPS
- $0.94+84.3%
- OCF Growth
- +22.5%
- FCF Growth
- +21.0%
- 52W High
- $74.20
- 52W Low
- $33.40
- 50D MA
- $63.92
- 200D MA
- $51.43
- Beta
- 1.82
- RSI (14)
- 57
- Avg Volume
- 220.25K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Red Violet delivered another record quarter with 23% revenue growth, margin expansion, and record customer additions, while also launching FOREWARN into home health care and outlining a larger capital deployment strategy.· August 10, 2026
- Revenue hit a record $26.7 million, up 23% year over year, with adjusted EPS of $0.50 and adjusted EBITDA of $11.2 million.
- Adjusted gross margin reached a record 86% and adjusted EBITDA margin hit a record 42%, showing strong operating leverage.
- IDI added a record 447 billable customers and ended with 10.9 thousand total customers; FOREWARN added 25.5 thousand users to 443 thousand.
- Management said 4 of 5 verticals posted all-time-high quarterly revenue, while real estate excluding FOREWARN remained modestly down.
- The company raised about $109 million in net proceeds in a public offering and plans to use it for working capital, general corporate purposes, and potential acquisitions.
Second quarter revenue was a record $26.7 million, up 23% from the prior year. Adjusted gross profit was $22.9 million, with adjusted gross margin at a record 86%, up 2 percentage points. Adjusted EBITDA was a record $11.2 million, up 48%, with adjusted EBITDA margin at 42%, up 7 percentage points. Adjusted net income rose 58% to $7.2 million, and adjusted earnings were $0.50 per diluted share. Cash flow from operations was a record $10.6 million, up 42%, and free cash flow was $7.2 million, up 50% from $4.8 million a year ago. Management reiterated expectations for full-year adjusted EBITDA margin to be in the high 30s; no explicit next-quarter revenue or EPS guidance was given.
Derek Dubner framed the quarter as proof that the identity intelligence market is accelerating, saying Red Violet’s platform is increasingly becoming a must-have amid rising fraud, AI-driven impersonation, and higher regulatory risk. He emphasized the company’s proprietary, AI-embedded entity resolution engine as a structural advantage over legacy competitors, and said the business is benefiting from broad demand across industries and from the K-shaped economy. He was especially upbeat about the record 447 IDI customer additions, the expansion of FOREWARN into home health care, and the company’s new strategic flexibility after the capital raise.
Daniel MacLachlan focused on operating leverage and balance sheet strength, noting that revenue, profitability, and cash flow all reached new highs together. He cited $26.7 million of revenue, $22.9 million of adjusted gross profit, 86% adjusted gross margin, $11.2 million of adjusted EBITDA, 42% adjusted EBITDA margin, and $7.2 million of adjusted net income; he also said cash from operations was $10.6 million and free cash flow was $7.2 million. On the balance sheet, he said cash and cash equivalents were $50 million at June 30, 2026 versus $43.6 million at year-end 2025, and that the company had repurchased 74.5 thousand shares year to date at an average price of $41.87, with $15.5 million remaining under the buyback program.
Analysts focused on what is driving the record 447 IDI customer additions, whether the wins are coming from greenfield demand or competitors, and how the company is progressing in public sector and federal accounts. Management said the mix is healthy across both new demand and competitive displacement, highlighted a large law enforcement win where Red Violet displaced an incumbent, and said federal is progressing but converting more slowly because of procurement and implementation cycles. Another key question centered on FOREWARN’s home health care expansion; management said the market includes an estimated 4 million home health aides and more than 12 thousand Medicare-certified agencies, but declined to quantify near-term revenue potential because it is a new entry and competitive market.
The call showed accelerating demand across the core IDI business, with record customer additions and multiple verticals hitting all-time-high revenue. Management sounded increasingly confident that AI, fraud pressure, and the move toward digital identity verification are expanding the addressable market and strengthening Red Violet’s competitive moat.
Real estate excluding FOREWARN was modestly down, and management said they remain tempered on a near-term recovery because of limited inventory, elevated interest rates, and high home prices. Federal public-sector adoption is still slower than management would like, and the home health care expansion is very early, so the new growth vectors still need to prove themselves.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 91.5%
- Shares Outstanding
- 14.11M
- Float Shares
- 12.91M
of shares held by institutions
162 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 956.44K | ▲ 23.74K |
| Blackrock, Inc. | 950.76K | ▲ 40.37K |
| Wasatch Advisors LP | 890.74K | ▼ 20.90K |
| Ashford Capital Management Inc | 686.82K | ▲ 84.00K |
| Trigran Investments, Inc. | 600.17K | ▼ 5.99K |
| Vanguard Capital Management LLC | 522.77K | ▲ 10.77K |
| Ophir Asset Management Pty Ltd | 509.19K | ▼ 161.24K |
| Royal Bank Of Canada | 339.44K | ▲ 108.36K |
| Geode Capital Management, LLC | 318.91K | ▲ 14.72K |
| State Street Corp | 290.37K | ▼ 15.87K |
| Herald Investment Management Ltd | 254.25K | ▲ 64.04K |
| Dimensional Fund Advisors LP | 216.85K | ▲ 10.15K |
Held by 130 ETFs
Biggest fund positions in RDVT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Strakosch Greg | other | 2,088 |
| Jun 4, 26 | LIVEK WILLIAM PAUL | other | 2,088 |
| Jun 4, 26 | Rubin Steven D | other | 2,179 |
| Jun 4, 26 | Stanton Lisa M. | other | 2,179 |
| Jun 1, 26 | DELL JEFFREY ALAN | sell | 5,000 |
| Jun 1, 26 | DELL JEFFREY ALAN | sell | 5,000 |
| Jun 1, 26 | Dubner Derek | sell | 6,000 |
| Jun 1, 26 | Dubner Derek | sell | 6,000 |
| Jun 1, 26 | MacLachlan Daniel | sell | 6,000 |
| Jun 1, 26 | MacLachlan Daniel | sell | 6,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RDVT coverage
Recent articles, reports, and earnings notes.
No research on RDVT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RDVT report →Red Violet Inc (RDVT) Stock Down 5.4% but Still Overvalued -- GF Score: 68/100
gurufocus.com · Aug 14
Red Violet Inc: Mission Critical Software Fuels Growth
seekingalpha.com · Aug 14
red violet to Present at the Midwest IDEAS Investor Conference
globenewswire.com · Aug 13
Red Violet Q2 Earnings Call Highlights
marketbeat.com · Aug 11
Wasatch Micro Cap Value Fund Q2 2026 Portfolio Review
seekingalpha.com · Aug 11
Red Violet, Inc. (RDVT) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 11
Red Violet, Inc. (RDVT) Q2 Earnings and Revenues Surpass Estimates
zacks.com · Aug 10
red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters' Option
globenewswire.com · Aug 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.